Astellas Pharma Incis A Japanese Multinational Pharmaceutical Companyestablished On April 12005Through The Merger Of Yamanouchi Pharmaceutical Co Ltdand Fujisawa Pharmaceutical Co Ltdheadquartered In Chuo Kutokyoastellas Operates Globallywith A Strong Presence In The Americaseuropeasiaand Oceania The Company Specializes In The Researchdevelopmentmanufactureand Commercialization Of Pharmaceutical Productsastellas Offers Treatments Across Various Therapeutic Areasincluding Urological Diseasescancernephrologyinfectious Diseasesmetabolic Diseasesimmunodeficiencyand Transplantationnotable Global Brands Include Prografvesicareprotopicharnaland Funguardastellas Also Has An Active Pipeline Of Drug Candidates Targeting Conditions Such As Urothelial Cancer And Acute Myeloid Leukemiawith Around 17 000 Employeesastellas Is Listed On The Tokyo Stock Exchange And Is Part Of The Nikkei 225 Index
